| Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review M Bizzarri, S Proietti, A Cucina, RJ Reiter Expert opinion on therapeutic targets 17 (12), 1483-1496, 2013 | 221 | 2013 |
| Pharmacodynamics and pharmacokinetics of inositol (s) in health and disease M Bizzarri, A Fuso, S Dinicola, A Cucina, A Bevilacqua Expert opinion on drug metabolism & toxicology 12 (10), 1181-1196, 2016 | 207 | 2016 |
| Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS F Facchinetti, M Bizzarri, S Benvenga, R D’Anna, A Lanzone, C Soulage, ... European Journal of Obstetrics & Gynecology and Reproductive Biology 195, 72-76, 2015 | 172 | 2015 |
| Inositols in insulin signaling and glucose metabolism A Bevilacqua, M Bizzarri International journal of endocrinology 2018 (1), 1968450, 2018 | 165 | 2018 |
| Melatonin and vitamin D3 synergistically down‐regulate Akt and MDM2 leading to TGFβ‐1‐dependent growth inhibition of breast cancer cells S Proietti, A Cucina, F D’Anselmi, S Dinicola, A Pasqualato, E Lisi, ... Journal of pineal research 50 (2), 150-158, 2011 | 139 | 2011 |
| Modulation of redox status and calcium handling by extremely low frequency electromagnetic fields in C2C12 muscle cells: A real-time, single-cell approach C Morabito, F Rovetta, M Bizzarri, G Mazzoleni, G Fanò, MA Mariggiò Free Radical Biology and Medicine 48 (4), 579-589, 2010 | 134 | 2010 |
| Evaluation of menstrual irregularities after COVID-19 vaccination: Results of the MECOVAC survey AS Laganà, G Veronesi, F Ghezzi, MM Ferrario, A Cromi, M Bizzarri, ... Open Medicine 17 (1), 475-484, 2022 | 133 | 2022 |
| Evidence for a biphasic apoptotic pathway induced by melatonin in MCF‐7 breast cancer cells A Cucina, S Proietti, F D’Anselmi, P Coluccia, S Dinicola, L Frati, ... Journal of pineal research 46 (2), 172-180, 2009 | 131 | 2009 |
| Inositols: from established knowledge to novel approaches S Dinicola, V Unfer, F Facchinetti, CO Soulage, ND Greene, M Bizzarri, ... International Journal of Molecular Sciences 22 (19), 10575, 2021 | 124 | 2021 |
| Melatonin down‐regulates MDM 2 gene expression and enhances p53 acetylation in MCF‐7 cells S Proietti, A Cucina, G Dobrowolny, F D'Anselmi, S Dinicola, MG Masiello, ... Journal of pineal research 57 (1), 120-129, 2014 | 124 | 2014 |
| Fractal analysis in a systems biology approach to cancer M Bizzarri, A Giuliani, A Cucina, F D’Anselmi, AM Soto, C Sonnenschein Seminars in cancer biology 21 (3), 175-182, 2011 | 124 | 2011 |
| Inositol: history of an effective therapy for Polycystic Ovary Syndrome CG Bizzarri M. European Review for Medical and Pharmacological Sciences 18, 1896-1903, 2014 | 120 | 2014 |
| Antiproliferative and Apoptotic Effects Triggered by Grape Seed Extract (GSE) versus Epigallocatechin and Procyanidins on Colon Cancer Cell Lines S Dinicola, A Cucina, A Pasqualato, F D’Anselmi, S Proietti, E Lisi, ... International journal of molecular sciences 13 (1), 651-664, 2012 | 119 | 2012 |
| Tumor and the microenvironment: a chance to reframe the paradigm of carcinogenesis? M Bizzarri, A Cucina | 117 | 2014 |
| Nutritional and acquired deficiencies in inositol bioavailability. Correlations with metabolic disorders S Dinicola, M Minini, V Unfer, R Verna, A Cucina, M Bizzarri International journal of molecular sciences 18 (10), 2187, 2017 | 115 | 2017 |
| Theoretical aspects of systems biology M Bizzarri, A Palombo, A Cucina Progress in biophysics and molecular biology 112 (1-2), 33-43, 2013 | 115 | 2013 |
| The rationale of the myo‐inositol and D‐chiro‐inositol combined treatment for polycystic ovary syndrome S Dinicola, TTY Chiu, V Unfer, G Carlomagno, M Bizzarri The Journal of Clinical Pharmacology 54 (10), 1079-1092, 2014 | 111 | 2014 |
| Results from the International Consensus Conference on myo-inositol and D-chiro-inositol in Obstetrics and Gynecology–assisted reproduction technology A Bevilacqua, G Carlomagno, S Gerli, M Montanino Oliva, P Devroey, ... Gynecological Endocrinology 31 (6), 441-446, 2015 | 106 | 2015 |
| Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients G Monastra, V Unfer, AH Harrath, M Bizzarri Gynecological Endocrinology 33 (1), 1-9, 2017 | 105 | 2017 |
| Broad spectrum anticancer activity of myo‐inositol and inositol hexakisphosphate M Bizzarri, S Dinicola, A Bevilacqua, A Cucina International Journal of Endocrinology 2016 (1), 5616807, 2016 | 105 | 2016 |
Pierpaolo ColucciaDirigente delle Professioni Sanitarie - Sapienza Universita' di Roma - Policlinico Umberto IVerified email at uniroma1.it
